LPS-induced inhibition of osteogenesis is TNF-α dependent in a murine tooth extraction model

Journal of Bone and Mineral Research

Volumn 24, Issue 10, 2009, Pages 1770-1781

  Tomomatsu, Nobuyoshi ^a   Aoki, Kazuhiro ^a   Alles, Neil ^a   Soysa, Niroshani S ^a   Hussain, Anower ^a   Nakachi, Hiroyuki ^a   Kita, Souma ^a   Shimokawa, Hitoyata ^a   Ohya, Keiichi ^a   Amagasa, Teruo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Lipopolysaccharide; NF B; Osteogenesis; TNF ; Tooth extraction

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE DEVELOPMENT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME INHIBITION; HEART DISEASE; IN VITRO STUDY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIODONTITIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TOOTH EXTRACTION;

ANIMALS; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INJECTIONS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOGENESIS; PEPTIDES; RNA, MESSENGER; TOOTH EXTRACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349922818     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090410     Document Type: Article

References (62)

1. Montes AH, Asensi V, Alvarez V, Valle E, Ocana MG, Meana A, Carton JA, Paz J, Fierer J, Celada A 2006 The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for gram-negative and haematogenous osteomyelitis. Clin Exp Immunol 143:404-413.
2. Itoh K, Udagawa N, Kobayashi K, Suda K, Li X, Takami M, Okahashi N, Nishihara T, Takahashi N 2003 Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 170:3688-3695. (Pubitemid 36359239)
3. Lynn WA, Golenbock DT 1992 Lipopolysaccharide antagonists. Immunol Today 13:271-276.
4. Ulevitch RJ, Tobias PS 1995 Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437-457.
5. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ 2001 Lysophospholipids- receptor revelations. Science 294:1875-1878.
6. Pober JS, Sessa WC 2007 Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803-815.
7. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL 2005 IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115:282-290.
8. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL 2004 Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo. J Immunol 173:4838-4846.
9. Brennan FM, Foey AD, Feldmann M 2006 The importance of T cell interactions with macrophages in rheumatoid cytokine production. Curr Top Microbiol Immunol 305:177-194. (Pubitemid 47400270)
10. Nanes MS 2003 Tumor necrosis factor-α: Molecular and cellular mechanisms in skeletal pathology. Gene 321:1-15.
11. Feldmann M, Brennan FM, Foxwell BM, Maini RN 2001 The role of TNF α and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 3:188-199.
12. Romas E, Gillespie MT, Martin TJ 2002 Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340-346. (Pubitemid 34154863)
13. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G 2002 Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 110:1419-1427. (Pubitemid 35396913)
14. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594-1602.
15. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ 1999 A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259. (Pubitemid 29063266)
16. Di Paola R, Mazzon E, Muia C, Crisafulli C, Terrana D, Greco S, Britti D, Santori D, Oteri G, Cordasco G, Cuzzocrea S 2007 Effects of etanercept, a tumour necrosis factor-α antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol 150:286-297. (Pubitemid 46221038)
17. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS 2000 Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology 141:3956-3964. (Pubitemid 30953507)
18. Gilbert LC, Rubin J, Nanes MS 2005 The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab 288:E1011-E1018. (Pubitemid 40547896)
19. Wahl EC, Aronson J, Liu L, Liu Z, Perrien DS, Skinner RA, Badger TM, Ronis MJ, Lumpkin CK Jr 2007 Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: Role of the TNF signaling axis. Toxicol Appl Pharmacol 220:302-310. (Pubitemid 46627849)
20. Lange U, Teichmann J, Muller-Ladner U, Strunk J 2005 Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody: A prospective open-label pilot study. Rheumatology (Oxford) 44:1546-1548. (Pubitemid 41742473)
21. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M 2006 Bone metabolism changes during anti-TNF-α therapy in patients with active rheumatoid arthritis. Ann NY Acad Sci 1069:420-427. (Pubitemid 43989885)
22. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S 2000 Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289:1550-1554. (Pubitemid 30677473)
23. Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, Sudo T, Kojima T, Okamoto F, Fukushima H, Okabe K, Ohya K, Ghosh S 2004 Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 10:617-624. (Pubitemid 38796853)
24. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H 2005 NFAT and Osterix cooperatively regulate bone formation. Nat Med 11:880-885. (Pubitemid 41161121)
25. v mutant mice. Bone 25:261-267. (Pubitemid 29406051)
26. Sato D, Nishimura K, Ishioka T, Kondo H, Kuroda S, Kasugai S 2005 Local application of simvastatin to rat incisor socket: Carrier-dependent effect on bone augmentation. J Oral Tissue Eng 2:81-85.
27. Suzuki Y, Aoki K, Saito H, Umeda M, Nitta H, Baron R, Ohya K 2006 A tumor necrosis factor-α antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice. J Periodontal Res 41:81-91.
28. Hussain Mian A, Saito H, Alles N, Shimokawa H, Aoki K, Ohya K 2008 Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo. J Bone Miner Metab 26:469-477.
29. Nonaka K, Fukuda S, Aoki K, Yoshida T, Ohya K 2006 Regional distinctions in cortical bone mineral density measured by pQCT can predict alterations in material property at the tibial diaphysis of the Cynomolgus monkey. Bone 38:265-272. (Pubitemid 43165792)
30. Saito H, Kojima T, Takahashi M, Horne WC, Baron R, Amagasa T, Ohya K, Aoki K 2007 A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. Arthritis Rheum 56:1164-1174. (Pubitemid 46608641)
31. Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M, Yamaguchi A, Deprez P, Mollat P, Murali R, Ohya K, Horne WC, Baron R 2006 A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest 116:1525-1534. (Pubitemid 43911007)
32. Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H 2000 Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935-943. (Pubitemid 30203066)
33. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
34. Koike M, Shimokawa H, Kanno Z, Ohya K, Soma K 2005 Effects of mechanical strain on proliferation and differentiation of bone marrow stromal cell line ST2. J Bone Miner Metab 23:219-225. (Pubitemid 40603204)
35. Sela J, Applebaum J, Uretzky G 1986 Osteogenesis induced by bone matrix is inhibited by inflammation. Biomater Med Devices Artif Organs 14:227-237. (Pubitemid 17219839)
36. May MJ, Marienfeld RB, Ghosh S 2002 Characterization of the IκB-kinase NEMO binding domain. J Biol Chem 277:45992-46000. (Pubitemid 35417584)
37. Zhou FH, Foster BK, Zhou XF, Cowin AJ, Xian CJ 2006 TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 21:1075-1088.
38. Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H 2007 TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 356:1004-1010. (Pubitemid 46529391)
39. Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H, Rosier RN 2006 Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB. Exp Cell Res 312:40-50. (Pubitemid 41668590)
40. Guo R, Yamashita M, Zhang Q, Zhou Q, Chen D, Reynolds DG, Awad HA, Yanoso L, Zhao L, Schwarz EM, Zhang YE, Boyce BF, Xing L 2008 Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283:23084-23092.
41. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS 2002 Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α. J Biol Chem 277:2695-2701. (Pubitemid 34953297)
42. Hikiji H, Shin WS, Koizumi T, Takato T, Susami T, Koizumi Y, Okai-Matsuo Y, Toyo-Oka T 2000 Peroxynitrite production by TNF-α and IL-1β: Implication for suppression of osteoblastic differentiation. Am J Physiol Endocrinol Metab 278:E1031-E1037. (Pubitemid 30439140)
43. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T 1993 IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808-1810. (Pubitemid 23244207)
44. Kishimoto T, Akira S, Narazaki M, Taga T 1995 Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
45. Franchimont N, Wertz S, Malaise M 2005 Interleukin-6: An osteotropic factor influencing bone formation? Bone 37:601-606.
46. Nishimura R, Moriyama K, Yasukawa K, Mundy GR, Yoneda T 1998 Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 13:777-785. (Pubitemid 28224193)
47. Littlewood AJ, Aarden LA, Evans DB, Russell RG, Gowen M 1991 Human osteoblastlike cells do not respond to interleukin-6. J Bone Miner Res 6:141-148.
48. Li Y, Backesjo CM, Haldosen LA, Lindgren U 2008 IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine 43:165-173.
49. Fang MA, Hahn TJ 1991 Effects of interleukin-6 on cellular function in UMR-106-01 osteoblastlike cells. J Bone Miner Res 6:133-139.
50. Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT 2002 Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277:16879-16887. (Pubitemid 34967713)
51. 3 stimulated osteocalcin gene transcription by tumor necrosis factor-α: Structural determinants within the vitamin D response element. Endocrinology 134:2524-2531. (Pubitemid 24170866)
52. 2+ transporters. Inflamm Bowel Dis 14:803-811. (Pubitemid 351898065)
53. 3 25-hydroxylase expression: A potential new mechanism for drug-induced osteomalacia. Biochem Biophys Res Commun 357:603-607. (Pubitemid 46653821)
54. Soysa N, Alles N, Shimokawa H, Jimi E, Aoki K, Ohya K 2009 Inhibition of the classical NF-κB pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab 27:131-139.
55. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN 2007 Endogenous TNFα lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-κB. J Bone Miner Res 22:646-655. (Pubitemid 351339092)
56. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, Fukuda T, Tsuji T, Iwamoto M, Murayama Y 2001 The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 72:774-778. (Pubitemid 33606560)
57. Nilsson M, Kopp S 2008 Gingivitis and periodontitis are related to repeated high levels of circulating tumor necrosis factor-alpha in patients with rheumatoid arthritis. J Periodontol 79:1689-1696.
58. Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z 2007 Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. Am J Pathol 170:388-398. (Pubitemid 47339216)
59. Kosar F, Aksoy Y, Ozguntekin G, Ozerol I, Varol E 2006 Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 8:270-274. (Pubitemid 44275312)
60. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F 2000 Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 248:67-76. (Pubitemid 30470006)
61. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, Einhorn TA 2001 Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169:285-294. (Pubitemid 32656656)
62. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Tsay A, Fitch J, Barnes GL, Graves DT, Einhorn TA 2003 Impaired fracture healing in the absence of TNF-α signaling: The role of TNF-α in endochondral cartilage resorption. J Bone Miner Res 18: 1584-1592. (Pubitemid 37022916)